The world of finance is constantly evolving, as new companies and industries emerge to challenge the status quo. One such company is iRhythm Technologies (NASDAQ:IRTC), a digital healthcare firm that offers device-based technology for ambulatory cardiac monitoring services. However, recent reports have raised significant concerns about the company’s financial health, leading equities researchers at StockNews.com to issue a “sell” rating on its stock.
